Dasatinib blocks cetuximab- and radiation-induced nuclear translocation of the epidermal growth factor receptor in head and neck squamous cell carcinoma

被引：0
|
作者：
Li, C. [1 ]
Iida, M. [1 ]
Dunn, E. F. [1 ]
Brand, T. M. [1 ]
Peet, C. R. [1 ]
Wheeler, D. L. [1 ]
机构：
[1] Univ Wisconsin, Madison, WI USA
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 07期
关键词：
D O I：
10.1016/S1359-6349(10)71891-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
  • [41] Concurrent cetuximab, cisplatin, and radiation for squamous cell carcinoma of the head and neck in vitro
    Zhang, Na
    Erjala, Kaisa
    Kulmala, Jarmo
    Qiu, Xueshan
    Sundvall, Maria
    Elenius, Klaus
    Grenman, Reidar
    RADIOTHERAPY AND ONCOLOGY, 2009, 92 (03) : 388 - 392
  • [42] Dual Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2 Inhibition in Squamous Cell Carcinoma of the Head and Neck; Is the Jury Still Out? Reply
    Harrington, Kevin J.
    Bourhis, Jean
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (17) : 2073 - +
  • [43] Gene alterations as predictors of radiation-induced toxicity in head and neck squamous cell carcinoma
    Whitney Sumner
    Xenia Ray
    Leisa Sutton
    Daniel Rebibo
    Francesco Marincola
    Parag Sanghvi
    Vitali Moiseenko
    Ida Deichaite
    Journal of Translational Medicine, 19
  • [44] Genetic Alterations as Predictors of Radiation-Induced Toxicity in Head and Neck Squamous Cell Carcinoma
    Sumner, W.
    Ray, X.
    Sutton, L.
    Rebibo, D.
    Sanghvi, P.
    Moiseenko, V.
    Deichaite, I.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E256 - E256
  • [45] Gene alterations as predictors of radiation-induced toxicity in head and neck squamous cell carcinoma
    Sumner, Whitney
    Ray, Xenia
    Sutton, Leisa
    Rebibo, Daniel
    Marincola, Francesco
    Sanghvi, Parag
    Moiseenko, Vitali
    Deichaite, Ida
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [46] Association of Epidermal Growth Factor Receptor Polymorphism, Skin Toxicity, and Outcome in Patients with Squamous Cell Carcinoma of the Head and Neck Receiving Cetuximab-Docetaxel Treatment
    Klinghammer, Konrad
    Knoedler, Maren
    Schmittel, Alexander
    Budach, Volker
    Keilholz, Ulrich
    Tinhofer, Ingeborg
    CLINICAL CANCER RESEARCH, 2010, 16 (01) : 304 - 310
  • [47] Combined inhibition of EMMPRIN and epidermal growth factor receptor prevents the growth and migration of head and neck squamous cell carcinoma cells
    Suzuki, Shinsuke
    Ishikawa, Kazuo
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 44 (03) : 912 - 917
  • [48] Phase II study of dasatinib in combination with cetuximab in recurrent/metastatic head and neck squamous cell carcinoma
    Stabile, Laura P.
    Egloff, Ann Marie
    Zhou, Pei
    Gooding, William E.
    Grandis, Jennifer R.
    Bauman, Julie E.
    CANCER RESEARCH, 2016, 76
  • [49] Identification of epidermal growth factor receptor (EGFR) polymorphisms that modify risk for squamous cell carcinoma of the head and neck (HNSCC).
    Fung, Christopher
    Trent, Kerry
    Joyce, Sonali
    Zhou, Pei
    Nukui, Tomoko
    Weeks, Daniel E.
    Diergaarde, Brenda
    Ye, Yuanqing
    Wu, Xifeng
    Yuan, Jian-Min
    Grandis, Jennifer
    Weissfeld, Joel L.
    Romkes, Marjorie
    Egloff, Ann Marie
    CANCER RESEARCH, 2013, 73 (08)
  • [50] Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status
    Hofman, P.
    Butori, C.
    Havet, K.
    Hofman, V.
    Selva, E.
    Guevara, N.
    Santini, J.
    Van Obberghen-Schilling, E.
    BRITISH JOURNAL OF CANCER, 2008, 98 (05) : 956 - 964
12345